Cargando…

Chronic inflammation initiates multiple forms of K-Ras-independent mouse pancreatic cancer in the absence of TP53

Chronic inflammation (CI) is a risk factor for pancreatic cancer (PC) including the most common type, ductal adenocarcinoma (PDAC), but its role and the mechanisms involved are unclear. To investigate the role of CI in PC, we generated genetic mouse models with pancreatic specific CI in the presence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Swidnicka-Siergiejko, A K, Gomez-Chou, S B, Cruz-Monserrate, Z, Deng, D, Liu, Y, Huang, H, Ji, B, Azizian, N, Daniluk, J, Lu, W, Wang, H, Maitra, A, Logsdon, C D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467016/ https://www.ncbi.nlm.nih.gov/pubmed/27991926 http://dx.doi.org/10.1038/onc.2016.461

Ejemplares similares

Microbiome—Friend or Foe of Pancreatic Cancer?
por: Daniluk, Jaroslaw, et al.
Publicado: (2021)

Prolonged 2-Day Esophageal pH-Metry with Impedance Monitoring Improves Symptom-Reflux Association Analysis
por: Swidnicka-Siergiejko, Agnieszka, et al.
Publicado: (2013)

Functional assessment of the right ventricle in patients with bronchial asthma of various severity
por: Mincewicz, Grzegorz, et al.
Publicado: (2021)

Endoscopic management of leaks and fistulas after bariatric surgery: a systematic review and meta-analysis
por: Rogalski, Pawel, et al.
Publicado: (2020)

Buried bumper syndrome: a rare complication of percutaneous endoscopic gastrostomy
por: Kurek, Krzysztof, et al.
Publicado: (2015)

Mutational status of K- ras and TP53 genes in primary sarcomas of the heart
por: Garcia, J M, et al.
Publicado: (2000)

Application of cyanoacrylate in difficult-to-arrest acute non-variceal gastrointestinal bleeding
por: Kurek, Krzysztof, et al.
Publicado: (2014)

The Significance of Ras Activity in Pancreatic Cancer Initiation
por: Logsdon, Craig D., et al.
Publicado: (2016)

Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53
por: Abrams, Stephen L., et al.
Publicado: (2022)

MGMT promoter hypermethylation and K-RAS, PTEN and TP53 mutations in tamoxifen-exposed and non-exposed endometrial cancer cases
por: Nagy, E, et al.
Publicado: (2014)

Comparative Effectiveness of Various Eradication Regimens for Helicobacter Pylori Infection in the Northeastern Region of Poland
por: Wasielica-Berger, Justyna, et al.
Publicado: (2022)

Expression of VEGF, EGF, and Their Receptors in Squamous Esophageal Mucosa, with Correlations to Histological Findings and Endoscopic Minimal Changes, in Patients with Different GERD Phenotypes
por: Wasielica-Berger, Justyna, et al.
Publicado: (2022)

Questionnaire-Based Study of 81 Patients in Poland to Evaluate the Course of Inflammatory Bowel Disease and the Effects of the COVID-19 Pandemic on Quality of Life and Mental State from February to June 2021
por: Owsianko, Natalia, et al.
Publicado: (2022)

Alterations of TP53 in microdissected transitional cell carcinoma of the human urinary bladder: high frequency of TP53 accumulation in the absence of detected mutations is associated with poor prognosis.
por: Abdel-Fattah, R., et al.
Publicado: (1998)

Absence of RAS and p53 mutations in thyroid carcinomas of children after Chernobyl in contrast to adult thyroid tumours.
por: Suchy, B., et al.
Publicado: (1998)

Comparison of the efficacy of two combined therapies for peptic ulcer bleeding: adrenaline injection plus haemoclipping versus adrenaline injection followed by bipolar electrocoagulation
por: Świdnicka-Siergiejko, Agnieszka, et al.
Publicado: (2014)

Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
por: Tesio, Melania
Publicado: (2023)

The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
por: Leroy, Bernard, et al.
Publicado: (2013)

The tumor suppressor Hic1 maintains chromosomal stability independent of Tp53
por: Szczepny, Anette, et al.
Publicado: (2018)

Elephant TP53-RETROGENE 9 induces transcription-independent apoptosis at the mitochondria
por: Preston, Aidan J., et al.
Publicado: (2023)

Methylene blue chromoendoscopy is more useful in detection of intestinal metaplasia in the stomach than mucosal pit pattern or vessel evaluation and predicts advanced Operative Link on Gastric Intestinal Metaplasia stages
por: Wasielica-Berger, Justyna, et al.
Publicado: (2023)

RITA displays anti-tumor activity in medulloblastomas independent of TP53 status
por: Gottlieb, Aline, et al.
Publicado: (2017)

RAS and TP53 can predict survival in adults with T‐cell lymphoblastic leukemia treated with hyper‐CVAD
por: Sakhdari, Ali, et al.
Publicado: (2019)

Nanocomplex-based TP53 gene therapy promotes anti-tumor immunity through TP53- and STING-dependent mechanisms
por: Moore, Ellen C., et al.
Publicado: (2018)

The TP53 fertility network
por: Paskulin, Diego d’Avila, et al.
Publicado: (2012)

Defects in mitophagy promote redox-driven metabolic syndrome in the absence of TP53INP1
por: Seillier, Marion, et al.
Publicado: (2015)

Absence of GSTT1 and polymorphisms in GSTP1 and TP53 are associated with the incidence of acne vulgaris
por: Ullah, Rehmat, et al.
Publicado: (2023)

The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes
por: McGraw, K L, et al.
Publicado: (2015)

TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
por: Wang, Haiwei, et al.
Publicado: (2022)

P457: COMPLEX CARYOTYPE IS AN INDEPENDENT RISK FACTOR IN TP53-MUTATED AML
por: Rausch, Christian, et al.
Publicado: (2023)

Optimisation of TP53 reporters by systematic dissection of synthetic TP53 response elements
por: Trauernicht, Max, et al.
Publicado: (2023)

Analysis of Tp53 Codon 72 Polymorphisms, Tp53 Mutations, and HPV Infection in Cutaneous Squamous Cell Carcinomas
por: Loeb, Keith R., et al.
Publicado: (2012)

TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer
por: Kawahara, Takashi, et al.
Publicado: (2019)

TP53: an oncogene in disguise
por: Soussi, T, et al.
Publicado: (2015)

TP53 in Myelodysplastic Syndromes
por: Jiang, Yan, et al.
Publicado: (2021)

Genomic and prognostic heterogeneity among RAS/BRAF (V600E)/TP53 co‐mutated resectable colorectal liver metastases
por: Berg, Kaja C. G., et al.
Publicado: (2021)

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
por: Langerød, A, et al.
Publicado: (2000)

Independent prognostic value of somatic TP53 gene mutations in 1794 breast cancer patients
por: Olivier, M, et al.
Publicado: (2005)

TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion
por: Eisenmann, Eric D., et al.
Publicado: (2022)

Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2 inhibitor in wild type TP53 tumors
por: Sonkin, Dmitriy
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_emimaq57rj4n28n3ph17iutb0l